Search
Search Results
##search.searchResults.foundPlural##
-
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
887PDF: 141HTML: 224 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3784PDF: 1741HTML: 2697 -
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
1522PDF: 894HTML: 1113Untitled: 205 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
4167PDF: 1384HTML: 2539 -
FACTORS PREDICTING MORBIDITY IN PATIENTS WITH DENGUE FEVER IN A TERTIARY CARE HOSPITAL
2521HTML: 9430DOCX: 1046Tables Dengue: 240 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1812PDF: 1350HTML: 643 -
I INCREASED RISK OF LYMPHOMA IN MEN INFECTED WITH TUBERCULOSIS
1262PDF: 542HTML: 415 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2246PDF: 1046HTML: 4100Cover Letter: 246Figure 1: 262Figure 2: 255Table 1: 238 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1478PDF: 729HTML: 1188Untitled: 207Untitled: 170Untitled: 159Untitled: 174Untitled: 182 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2411PDF: 1048HTML: 7699Untitled: 306Fig2: 212Fig3: 200Fig4: 215 -
Early Diagnosis of Gaucher Disease and ASMD in Sardinia: the “ICHNOS” Project
738PDF: 656Suppl. Files: 155Html: 167 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1751PDF: 643HTML: 295 -
CAN WE PREDICT INCIPIENT DIABETES MELLITUS IN PATIENTS WITH TRANSFUSION DEPENDENT β-THALASSEMIA (β-TDT) REFERRED WITH A HISTORY OF PREDIABETES? Risk factors for incipient diabetes in thalassemia
1179PDF: 1403HTML: 178 -
GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload
4064PDF: 1190HTML: 472 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3418PDF: 1625HTML: 289 -
Respiratory function in pediatric African SCA patients underwent bone marrow transplantation
2206PDF: 817HTML: 1079Spirometry in SCA patients before transplant: 236Spirometry in SCA patients post transplant: 207 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
987PDF: 719Suppl. Files: 150HTML: 160 -
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1463PDF: 907HTML: 10098cover letter to the editor: 198tile page: 278 -
CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2575PDF: 991HTML: 2257 -
DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura
895PDF: 765HTML: 239 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1378PDF: 1102HTML: 437 -
PERSISTENT COLONIC SCHISTOSOMIASIS AMONG SYMPTOMATIC RURAL INHABITANTS IN THE EGYPTIAN NILE DELTA Colonic schistosomiasis among rurals of the Egyptian Nile delta
1710PDF: 547MP4: 459Html: 305 -
CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
1788PDF: 778HTML: 2355 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2900PDF: 963HTML: 304 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2316PDF: 763HTML: 2149Untitled: 255Untitled: 176Untitled: 209Untitled: 182Untitled: 199Untitled: 210Untitled: 216 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2621PDF: 1768HTML: 600







